Tenders/AUTOMATED IMMUNOHISTOCHEMISTRY SYSTEM - In situ hybridization (ISH)
Awarded🇬🇷GreeceSupplies

AUTOMATED IMMUNOHISTOCHEMISTRY SYSTEM - In situ hybridization (ISH)

Auto-translated from Greek
Original title: ΑΥΤΟΜΑΤΟ ΣΥΣΤΗΜΑ ΑΝΟΣΟΪΣΤΟΧΗΜΕΙΑΣ - Ιn situ υβριδισμου (ΙSH)
Π.Γ.Ν. ΛΑΡΙΣΑΣ
Published: Sep 18, 2026
Updated: Sep 18, 2026
Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector. Located in Greece, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 30,000.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from Greek
2. ACCOMPANYING EQUIPMENT FOR AUTOMATED IMMUNOHISTOCHEMISTRY SYSTEM - In situ hybridization (ISH) SLIDES/YEAR: 2,300 Technical specifications for an automated immunohistochemistry and in situ hybridization system 1. It must be a desktop and fully automated system for immunohistochemistry and in situ hybridization procedures. That is, it must perform all immunohistochemistry and in situ hybridization procedures in one device without human intervention. 2. It must have the capability to simultaneously perform single immunohistochemical staining, double immunohistochemical staining, and in situ hybridization staining (FISH & CISH). 3. It must be able to simultaneously perform immunostains and chromogenic in situ hybridization stains for EBER, CMV, Kappa, Lambda, and HPV, using the same detection kit. The detection kit must be able to perform at least 200 tests. Reagents for the complete execution of automated in situ hybridization for the detection of the early RNA of the EBV virus (100 tests), 4. It must be able to perform double staining on the same slide either sequentially or in parallel using individual primary antibodies or mixtures thereof (cocktail) and using an appropriate diagnostic kit. 5. It must have a capacity of at least 30 slides and allow continuous loading during operation without interrupting the staining process of the remaining slides. 6. The offered system must have participated in external quality control procedures (NordiQC, UK NEQAS, or a similarly recognized organization). Participation must be proven by printouts from the official websites of the external quality control organizations. 7. It must have a waste separation system for non-hazardous/non-toxic waste and toxic/hazardous waste, which must be directed to independent closed containers, ensuring maximum possible economy in waste management and disposal costs and the safety of the environment and laboratory personnel. 8. For the automatic execution of the immunohistochemistry procedure, the amount of primary antibody used must be a maximum of 150 μl per slide. It must be an open system regarding antibodies from any manufacturer. 9. It must have an automatic control and notification system for the availability of reagents/primary antibodies before starting the immunohistochemistry and in situ hybridization procedure, and for the waste level, so that there is no risk of system shutdown during the staining process due to lack of reagents or waste overflow. 10. It must have standard protocols for executing immunohistochemistry and in situ hybridization procedures, which the system user can freely modify according to the laboratory's requirements. 11. The system must have the ability to adjust the incubation time of the primary antibody and other reagents, the method and time of epitope retrieval, and the temperature, by groups of slide positions or for each slide individually. 12. The system must have the capability, during the processing cycle and without human intervention, to prepare the chromogen to be used to achieve maximum staining quality. 13. It must use a barcode system and optical data capture (camera) for identifying reagents and slides and activating the staining process, even when the slides have a handwritten label. 14. It must allow the use of the label printed by the system even if it is not recognized by the automatic identification system. 15. Manual identification of antibody containers and detection kits is permitted in case of failure of the identification system. 16. The automatic system must operate using positively charged microscope slides from any manufacturer and ensure that sections do not dry out even in...

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on September 18, 2026. Last refreshed 61 days ago. Original language: Greek. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Π.Γ.Ν. ΛΑΡΙΣΑΣ

Π.Γ.Ν. ΛΑΡΙΣΑΣ has issued 84 procurement notices on BidsFactory, including 4 currently open and 62 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Industry & Manufacturing. All notices are published for Greece. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: November 17, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to ΒΙΟΔΥΝΑΜΙΚΗ ΑΝΩΝΥΜΟΣ ΕΜΠΟΡΙΚΗ ΤΕΧΝΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Π.Γ.Ν. ΛΑΡΙΣΑΣ in Greece. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

ΒΙΟΔΥΝΑΜΙΚΗ ΑΝΩΝΥΜΟΣ ΕΜΠΟΡΙΚΗ ΤΕΧΝΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ was awarded the contract for €29,627. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Greece. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Sectors & Categories